Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  BB Biotech AG    BION   CH0038389992

BB BIOTECH AG

(BION)
  Report  
Delayed Quote. Delayed Swiss Exchange - 12/13 06:18:39 am
68.15 CHF   +1.04%
11/20BB BIOTECH AG : Nomination
CO
10/18BB BIOTECH : publishes its interim report
EQ
10/18BB BIOTECH AG : Political factors weigh on biotech equity markets
EQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Most relevant news about BB BIOTECH AG
11/20BB BIOTECH AG : Nomination
CO
10/18BB BIOTECH : publishes its interim report
EQ
10/18BB BIOTECH AG : Political factors weigh on biotech equity markets
EQ
10/18BB BIOTECH AG : 3rd quarter results
CO
09/30BB BIOTECH AG : 3rd quarter report
CO
07/19BB BIOTECH : publishes its interim report
EQ
07/19BB BIOTECH AG : Consolidation leaves a mark on results in the second quarter
EQ
06/30BB BIOTECH AG : Half-year report
CO
05/27BB BIOTECH AG : Notification and public disclosure of transactions by persons
EQ
04/26BB BIOTECH AG : Focus on long-term innovation leads to a strong first quarter of..
EQ
04/26BB BIOTECH : reports results
EQ
04/11BB BIOTECH : concludes its share buyback program and launches a new buyback prog..
EQ
03/31BB BIOTECH AG : 1st quarter report
CO
03/25BB BIOTECH AG : Ex-dividend day for final dividend
FA
03/21BB BIOTECH AG : Shareholders at the general meeting vote in favor of all proposa..
EQ
More most relevant news
All news about BB BIOTECH AG
11/20BB BIOTECH AG : Nomination
CO
10/18BB BIOTECH : publishes its interim report
EQ
10/18BB BIOTECH AG : Political factors weigh on biotech equity markets
EQ
10/18BB BIOTECH AG : 3rd quarter results
CO
09/30BB BIOTECH AG : 3rd quarter report
CO
07/19BB BIOTECH : publishes its interim report
EQ
07/19BB BIOTECH AG : Consolidation leaves a mark on results in the second quarter
EQ
06/30BB BIOTECH AG : Half-year report
CO
05/27BB BIOTECH AG : Notification and public disclosure of transactions by persons
EQ
05/14ASHTEAD : What's at stake for Europe Inc in a trade spat with Washington
RE
More news
News in other languages on BB BIOTECH AG
11/20ZURICH STOCK EXCHANGE : Morning Briefing - Markt Schweiz
11/20Principales informations avant-Bourse
11/20BB Biotech élargit son conseil d'administration à cinq membres
11/20BB Biotech erweitert Verwaltungsrat auf fünf Personen
11/20BB BIOTECH AG : Erweiterung des Verwaltungsrats
10/18BB Biotech bascule dans le rouge au troisième trimestre
10/18BB Biotech rutscht im dritten Quartal ins Minus
10/18BB BIOTECH : veröffentlicht Zwischenbericht
10/18BB BIOTECH AG : Politische Faktoren beeinflussen Biotechaktienmärkte
10/18BB Biotech AG veröffentlicht Zwischenbericht
Press releases
10/18BB BIOTECH : publishes its interim report
EQ
10/18BB BIOTECH AG : Political factors weigh on biotech equity markets
EQ
07/19BB BIOTECH : publishes its interim report
EQ
07/19BB BIOTECH AG : Consolidation leaves a mark on results in the second quarter
EQ
05/27BB BIOTECH AG : Notification and public disclosure of transactions by persons
EQ
More press releases
Sector news : Biotechnology & Medical Research - NEC
02:49aGermany To Probe Inspector Vale Used -- WSJ
DJ
12/11KINIKSA PHARMACEUTICALS : Kite in Mavrilimumab Collaboration
DJ
12/10REGENERON PHARMACEUTICALS : Sanofi to Restructure Collaboration for Kevzara, Pra..
DJ
12/10AMGEN : Phase 3 Study Combining Kyprolis, Darzalex Met Primary Endpoint
DJ
12/10Regeneron Shares Fall Premarket as Sanofi Signals Possible Stake Sale
DJ
More sector news : Biotechnology & Medical Research - NEC
Upcoming event on BB BIOTECH AG